This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliografia
Barnes J, Mills SY, Abbot NC, Willoughby M, Ernst E (1998) Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies. Br J Clin Pharmacol 45:496–500
De Smet PAGM (2004) Health risks of herbal remedies: an update. Clin Pharmacol Ther 76:1–17
Eisenberg JM (2000) Continuing education meets the learning organisation: the challenge of a systems approach to patients safety. J Contin Educ Health Prof 20:197–207
Eisenberg L (1999) Does social medicine still matter in an era of molecular medicine? J Urban Healh 76:164–175
Ernst E (1998) Harmles herbs? A review of the recent literature. Am J Med 104:170–178
Friedman MA, Woodcock J, Lumpkin MM, Shuren JE, Hass AE, Thompson LJ (1999) The Safety of Newly Approved Medicines: Do Recent Market Removals Mean There Is a Problem? JAMA 281:1728–1734
Lazarou J, Pomeranz BJ, Corey PN (1998) Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies. JAMA 279:1200–1205
Moore TJ, Psaty BM, Furberg CD (1998) Time to Act on Drug Safety. JAMA 279:1571–1573
Morris CA, Avorn J (2003) Internet marketing of herbal products. JAMA 290:1505–1509
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this chapter
Cite this chapter
(2006). I rischi in fitoterapia: l’entità del problema. In: Fitofarmacovigilanza. Springer, Milano. https://doi.org/10.1007/88-470-0479-9_3
Download citation
DOI: https://doi.org/10.1007/88-470-0479-9_3
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0478-8
Online ISBN: 978-88-470-0479-5
eBook Packages: MedicineMedicine (R0)